These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 11940546)

  • 1. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.
    Atkinson C; Stewart S; Upton PD; Machado R; Thomson JR; Trembath RC; Morrell NW
    Circulation; 2002 Apr; 105(14):1672-8. PubMed ID: 11940546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins.
    Morrell NW; Yang X; Upton PD; Jourdan KB; Morgan N; Sheares KK; Trembath RC
    Circulation; 2001 Aug; 104(7):790-5. PubMed ID: 11502704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family.
    Thomson JR; Machado RD; Pauciulo MW; Morgan NV; Humbert M; Elliott GC; Ward K; Yacoub M; Mikhail G; Rogers P; Newman J; Wheeler L; Higenbottam T; Gibbs JS; Egan J; Crozier A; Peacock A; Allcock R; Corris P; Loyd JE; Trembath RC; Nichols WC
    J Med Genet; 2000 Oct; 37(10):741-5. PubMed ID: 11015450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.
    ; Lane KB; Machado RD; Pauciulo MW; Thomson JR; Phillips JA; Loyd JE; Nichols WC; Trembath RC
    Nat Genet; 2000 Sep; 26(1):81-4. PubMed ID: 10973254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension.
    Machado RD; Rudarakanchana N; Atkinson C; Flanagan JA; Harrison R; Morrell NW; Trembath RC
    Hum Mol Genet; 2003 Dec; 12(24):3277-86. PubMed ID: 14583445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling molecules in nonfamilial pulmonary hypertension.
    Du L; Sullivan CC; Chu D; Cho AJ; Kido M; Wolf PL; Yuan JX; Deutsch R; Jamieson SW; Thistlethwaite PA
    N Engl J Med; 2003 Feb; 348(6):500-9. PubMed ID: 12571257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.
    Machado RD; Pauciulo MW; Thomson JR; Lane KB; Morgan NV; Wheeler L; Phillips JA; Newman J; Williams D; Galiè N; Manes A; McNeil K; Yacoub M; Mikhail G; Rogers P; Corris P; Humbert M; Donnai D; Martensson G; Tranebjaerg L; Loyd JE; Trembath RC; Nichols WC
    Am J Hum Genet; 2001 Jan; 68(1):92-102. PubMed ID: 11115378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension.
    Takahashi H; Goto N; Kojima Y; Tsuda Y; Morio Y; Muramatsu M; Fukuchi Y
    Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L450-8. PubMed ID: 16361357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3.
    Upton PD; Davies RJ; Tajsic T; Morrell NW
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1135-45. PubMed ID: 23937428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice.
    Song Y; Coleman L; Shi J; Beppu H; Sato K; Walsh K; Loscalzo J; Zhang YY
    Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H677-90. PubMed ID: 18552156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of overactive transforming growth factor-β signaling by prostacyclin analogs in pulmonary arterial hypertension.
    Ogo T; Chowdhury HM; Yang J; Long L; Li X; Torres Cleuren YN; Morrell NW; Schermuly RT; Trembath RC; Nasim MT
    Am J Respir Cell Mol Biol; 2013 Jun; 48(6):733-41. PubMed ID: 23418342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension.
    Rudarakanchana N; Flanagan JA; Chen H; Upton PD; Machado R; Patel D; Trembath RC; Morrell NW
    Hum Mol Genet; 2002 Jun; 11(13):1517-25. PubMed ID: 12045205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutations of genes coding for TGF-beta receptors (BMPR2 and ALK-1) in primary pulmonary arterial hypertension].
    Humbert M
    J Soc Biol; 2002; 196(1):53-8. PubMed ID: 12134634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pulmonary acinar aplasia: reduction of transforming growth factor-beta ligands and receptors.
    Chen MF; Gray KD; Prentice MA; Mariano JM; Jakowlew SB
    Pediatr Res; 1999 Jul; 46(1):61-70. PubMed ID: 10400136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.
    Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW
    Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia.
    Beppu H; Ichinose F; Kawai N; Jones RC; Yu PB; Zapol WM; Miyazono K; Li E; Bloch KD
    Am J Physiol Lung Cell Mol Physiol; 2004 Dec; 287(6):L1241-7. PubMed ID: 15286002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of transforming growth factor-beta superfamily receptors in rat eyes.
    Obata H; Kaji Y; Yamada H; Kato M; Tsuru T; Yamashita H
    Acta Ophthalmol Scand; 1999 Apr; 77(2):151-6. PubMed ID: 10321529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension.
    De Caestecker M; Meyrick B
    Respir Res; 2001; 2(4):193-7. PubMed ID: 11686884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension.
    Nishihara A; Watabe T; Imamura T; Miyazono K
    Mol Biol Cell; 2002 Sep; 13(9):3055-63. PubMed ID: 12221115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
    Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
    N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.